(Q43723302)

2 July 2019

title

Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity (English)

1 reference

2 July 2019

1 reference

1 reference

Agnes L-F Chan

1

1 reference

2 July 2019

Wen-Shin Chang

2

1 reference

2 July 2019

Li-Min Chen

3

1 reference

2 July 2019

Chi-Ming Lee

4

1 reference

2 July 2019

Chiao-En Chen

5

1 reference

2 July 2019

Chun-Mao Lin

6

1 reference

2 July 2019

Jau-Lang Hwang

7

1 reference

2 July 2019

language of work or name

English

0 references

publication date

27 March 2009

1 reference

2 July 2019

full work available at URL

https://www.mdpi.com/1420-3049/14/4/1342/pdf?version=1403112549

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.3390/molecules14041342?email=unpaywall_01@example.com

published in

Molecules

1 reference

2 July 2019

volume

14

1 reference

2 July 2019

issue

4

1 reference

2 July 2019

page(s)

1342-1352

1 reference

2 July 2019

Creative Commons Attribution 4.0 International

copyright license

start time

27 March 2009

1 reference

April 2022 Public Data File from Crossref

0 references

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.3390/molecules14041342?email=unpaywall_01@example.com

access restriction status

open access

1 reference

inferred from online access status

cites work

Next generation topoisomerase I inhibitors: Rationale and biomarker strategies

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Topoisomerase I inhibitors for the treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Impact of topoisomerase II inhibition on cytokine and chemokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Anti-invasive and metastatic activities of evodiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Quantitative analyses of indoloquinazoline alkaloids in Fructus Evodiae by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Cytotoxicity and DNA topoisomerase inhibitory activity of constituents isolated from the fruits of Evodia officinalis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Overexpression of human DNA topoisomerase I in insect cells using a baculovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Isodiospyrin as a novel human DNA topoisomerase I inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES14041342

Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation

21 January 2018

1 reference

12 December 2020

Kinetic Analysis of DNA and RNA Strand Transfer Reactions Catalyzed by Vaccinia Topoisomerase

1 reference

12 December 2020

Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats

1 reference

12 December 2020

DNA topoisomerase inhibitor, etoposide, enhances GC-box-dependent promoter activity via Sp1 phosphorylation

1 reference

12 December 2020

An engineered mutant of vaccinia virus DNA topoisomerase I is sensitive to the anti-cancer drug camptothecin

1 reference

12 December 2020

Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli

1 reference

12 December 2020

Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110

1 reference

12 December 2020

The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B

1 reference

12 December 2020

10.3390/MOLECULES14041342

Identifiers

DOI

1 reference

2 July 2019

PMC publication ID

6254212

1 reference

2 July 2019

PubMed publication ID

19384267

1 reference

2 July 2019